Coeloglossum viride var. bracteatum extract protects against amyloid toxicity in rat prefrontal cortex neurons

International Journal of Clinical and Experimental Medicine

Volumn 3, Issue 1, 2010, Pages 88-94

  Qin, Xiao Yan ^a,b   Cui, Jia ^a,b   Zhang, Yan ^a,b  

^a MINZU UNIVERSITY OF CHINA   (China)

^b PEKING UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Amyloid ; CE; Coeloglossum viride var.bracteatum; Traditional chinese medicine

Indexed keywords

AMYLOID BETA PROTEIN[25-35]; CASPASE 3; COELOGLOSSUM VIRIDE EXTRACT; DACTYLORHIN A; DACTYLORHIN B; HERBACEOUS AGENT; LOROGLOSSIN; MILITARINE; NEUROPROTECTIVE AGENT; PLANT EXTRACT; PROTEIN BCL 2; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; BRAIN CELL; CELL VIABILITY; COELOGLOSSUM VIRIDE; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; DRUG STRUCTURE; ENZYME ACTIVATION; ENZYME REGULATION; IN VITRO STUDY; MEDICINAL PLANT; NERVE CELL CULTURE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PREFRONTAL CORTEX; RAT; REGULATORY MECHANISM; STRUCTURE ACTIVITY RELATION; TRADITIONAL MEDICINE; VARIETAS;

COELOGLOSSUM VIRIDE; RATTUS;

EID: 77955474889     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Bondareff W, Mountjoy CQ and Roth M. Loss of neurons of origin of the adrenergic projection to cerebral cortex (nucleus locus ceruleus) in senile dementia. Neurology 1982; 32: 164-168.
2. Colle MA, Duyckaerts C, Laquerriere A, Pradier L, Czech C, Checler F and Hauw JJ. Laminar specific loss of isocortical presenilin 1 immunoreactivity in Alzheimer's disease. Correlations with the amyloid load and the density of taupositive neurofibrillary tangles. Neuropathol Appl Neurobiol 2000; 26: 117-123.
3. Lippa CF, Hamos JE, Pulaski-Salo D, DeGennaro LJ and Drachman DA. Alzheimer's disease and aging: effects on perforant pathway perikarya and synapses. Neurobiol Aging 1992; 13: 405-411.
4. Gomez-Isla T, Growdon WB, McNamara M, Newell K, Gomez-Tortosa E, Hedley-Whyte ET and Hyman BT. Clinicopathologic correlates in temporal cortex in dementia with Lewy bodies. Neurology 1999; 53: 2003-2009.
5. Gomez-Isla T, Hollister R, West H, Mui S, Growdon JH, Petersen RC, Parisi JE and Hyman BT. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann Neurol. 1997; 41: 17-24.
6. Gomez-Isla T, Price JL, McKeel DW, Jr., Morris JC, Growdon JH and Hyman BT. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J Neurosci. 1996; 16: 4491-4500.
7. Hohmann GF, Wenk GL, Lowenstein P, Brown ME and Coyle JT. Age-related recurrence of basal forebrain lesion-induced cholinergic deficits. Neurosci Lett 1987; 82: 253-259.
8. Pearson RC and Powell TP. Anterograde vs. retrograde degeneration of the nucleus basalis medialis in Alzheimer's disease. J Neural Transm Suppl 1987; 24: 139-146.
9. Mesulam MM. Alzheimer plaques and cortical cholinergic innervation. Neuroscience 1986; 17: 275-276.
10. Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT and Delon MR. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 1982; 215: 1237-1239.
11. Whitehouse PJ, Price DL, Clark AW, Coyle JT and DeLong MR. Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann Neurol 1981; 10: 122-126.
12. Weinstock M. Possible role of the cholinergic system and disease models. J Neural Transm Suppl 1997; 49: 93-102.
13. Francis PT, Webster MT, Chessell IP, Holmes C, Stratmann GC, Procter AW, Cross AJ, Green AR and Bowen DM. Neurotransmitters and second messengers in aging and Alzheimer's disease. Ann N Y Acad Sci 1993; 695: 19-26.
14. Lorenzo A and Yankner BA. Amyloid fibril toxicity in Alzheimer's disease and diabetes. Ann N Y Acad Sci 1996; 777: 89-95.
15. Zhang D, Liu G, Shi J and Zhang J. Coeloglossum viride var. bracteatum extract attenuates D-galactose and NaNO2 induced memory impairment in mice. J Ethnopharmacol 2006; 104: 250-256.
16. Huang SY, Li GQ, Shi JG and Mo SY. Chemical constituents of the rhizomes of Coeloglossum viride var. bracteatum. J Asian Nat Prod Res 2004; 6: 49-61.
17. Zhang D, Zhang Y, Liu G and Zhang J. Dactylorhin B reduces toxic effects of beta-amyloid fragment (25-35) on neuron cells and isolated rat brain mitochondria. Naunyn Schmiedebergs Arch Pharmacol 2006; 374: 117-125.
18. Yamatsuji T, Okamoto T, Takeda S, Murayama Y, Tanaka N and Nishinoto I. Expression of V642 APP mutant causes cellular apoptosis as Alzheimer trait-linked phenotype. EMBO J. 1996; 15: 498-509.
19. Games D, Adams D, Alesandrini R, Barbour R and Berthelette P. Alzheimer-type neuropathology in transgenic mice overexpression V717F beta-amyloid precursor protein. Nature 1995; 373: 523-527.
20. Holcomb L, Gordon MN, McGowan E, Yu X and Benkovic S. Accelerate Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat Med. 1998; 4: 97-100.
21. Nijhawan D, Honarpour N and Wang X. Apoptosis in neural development and disease. Annu Rev Neurosci. 2000; 23: 73-87.
22. Bursztajn S, De Souza R and McPhie DL. Overexpression in neurons of human presenilin-1 familial Alzheimer disease mutant does not enhance apoptosis. J Neurosci 1998; 18: 9790-9799.
23. Shoji M, Iwakami N, Takeuchi S, Waragai M, Suzuki M, Kanazawa I, Lippa CF, Ono S and Okazawa H. JNK activation is associated with intracellular beta-amyloid accumulation. Brain Res Mol Brain Res 2000; 85: 221-233.
24. Qin XY, Cheng Y, Cui J, Zhang Y and Yu LC. Potential protection of curcumin against amyloid beta-induced toxicity on cultured rat prefrontal cortical neurons. Neurosci Lett 2009; 463: 158-161.
25. Wang X, Liu P, Zhu H, Xu Y, Ma C, Dai X, Huang L, Liu Y, Zhang L and Qin C. miR-34a, a microRNA up-regulated in a double transgenic mouse model of Alzheimer's disease, inhibits bcl2 translation. Brain Res Bull 2009; 80: 268-273.
26. Sultana R, Banks WA and Butterfield DA. Decreased levels of PSD95 and two associated proteins and increased levels of BCl2 and caspase 3 in hippocampus from subjects with amnestic mild cognitive impairment: Insights into their potential roles for loss of synapses and memory, accumulation of Abeta, and neurodegeneration in a prodromal stage of Alzheimer's disease. J Neurosci Res 88: 469-477.